Shopping Cart
- Remove All
Your shopping cart is currently empty
Bofutrelvir (FB2001) is a SARS-CoV-2 3CL protease inhibitor with antiviral activity for the study of novel coronavirus pneumonia (COVID-19) infections.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $198 | In Stock | |
| 5 mg | $572 | In Stock | |
| 10 mg | $813 | In Stock | |
| 25 mg | $1,190 | In Stock | |
| 50 mg | $1,630 | In Stock | |
| 100 mg | $2,180 | In Stock |
| Description | Bofutrelvir (FB2001) is a SARS-CoV-2 3CL protease inhibitor with antiviral activity for the study of novel coronavirus pneumonia (COVID-19) infections. |
| Targets&IC50 | Mpro:53 nM |
| In vitro | MPro Inhibitor 11a (24 hours) exhibits in vitro inhibitory activity against SARS-CoV-2 and its variants when combined with remdesivir treatment[1]. |
| In vivo | In K18-hACE2 mice infected with the SARS-CoV-2 Delta variant, MPro Inhibitor 11a (100 and 200 mg/kg; intraperitoneal injection; administered once daily at 100 and 200 mg/kg on day 0 and twice daily on days 1, 2, and 3 for 4 consecutive days) demonstrated a dose-dependent efficacy against lung viral titers, effectively reducing lung viral loads[2]. |
| Synonyms | MPro Inhibitor 11a, FB2001, DC-402234 |
| Molecular Weight | 452.55 |
| Formula | C25H32N4O4 |
| Cas No. | 2103278-86-8 |
| Smiles | C(N[C@@H](CC1CCCCC1)C(N[C@@H](C[C@H]2C(=O)NCC2)C=O)=O)(=O)C3=CC=4C(N3)=CC=CC4 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: 30 mg/mL (66.29 mM), Sonication is recommended. DMF: 30 mg/mL (66.29 mM), Sonication is recommended. DMSO: 80 mg/mL (176.78 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
Ethanol/DMF/DMSO
| |||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.